Conference
ASSESSMENT OF THE COST-EFFECTIVENESS OF RISK FACTOR GUIDED PROPHYLAXIS WITH PALIVIZUMAB FOR THE PREVENTION OF SEVERE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN COLOMBIAN INFANTS BORN AT 32-35 WEEKS' GESTATIONAL AGE
Authors
Rodriguez-Martinez CE; Ordonez J; Carbonell-Estrany X; Fullarton J; Keary I; Rodgers-Gray B; D'Apremont I; Espinosa SM; Ribeiro PA; Stein R
Volume
26
Pagination
pp. S156-S156
Publisher
ELSEVIER SCIENCE INC
Publication Date
December 2023
Conference proceedings
VALUE IN HEALTH
Issue
12
ISSN
1098-3015